Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	92699
Country	China

Received	2024-02-03 01:49
Peer-Review Started	2024-02-03 01:49
To Make the First Decision
Return for Revision	2024-04-18 01:41
Revised	2024-05-01 15:29
Second Decision	2024-06-12 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-12 07:31
Articles in Press	2024-06-12 07:31
Publication Fee Transferred	2024-06-17 16:05
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-02 00:22
Publish the Manuscript Online	2024-08-08 04:58

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Camrelizumab, apatinib and hepatic artery infusion chemotherapy combined with microwave ablation for advanced hepatocellular carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Meng-Xuan Zuo, Chao An, Yu-Zhe Cao, Jia-Yu Pan, Lu-Ping Xie, Xin-Jing Yang, Wang Li and Pei-Hong Wu
ORCID	Author(s) ORCID Number Meng-Xuan Zuo http://orcid.org/0000-0003-3589-7316 Chao An http://orcid.org/0000-0002-1096-4183 Wang Li http://orcid.org/0000-0002-4293-8182 Pei-Hong Wu http://orcid.org/0000-0001-8008-1872
Funding Agency and Grant Number
Corresponding Author	Pei-Hong Wu, Doctor, Doctor, Doctor, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, No. 651 Dongfeng Road East, Yuexiu District, Guangzhou 510060, Guangdong Province, China. wuph@sysucc.org.cn
Key Words	Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Molecular targeting agent; Programmed cell death protein 1 inhibitors; Microwave ablation
Core Tip	Microwave ablation (MWA) and hepatic arterial infusion chemotherapy (HAIC) are important locoregional therapy for advanced hepatocellular carcinoma (HCC). HAIC with anti-angiogenesis agents and programmed cell death protein 1 inhibitiors [camrelizumab plus apatinib and hepatic artery infusion chemotherapy (TRIPLET)] followed by MWA contribute to better outcome than TRIPLET alone. Combination of locoregional therapy improve prognosis of advanced HCC.
Publish Date	2024-08-08 04:58
Citation	<p>Zuo MX, An C, Cao YZ, Pan JY, Xie LP, Yang XJ, Li W, Wu PH. Camrelizumab, apatinib and hepatic artery infusion chemotherapy combined with microwave ablation for advanced hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2024; 16(8): 3481-3495</p>
URL	https://www.wjgnet.com/1948-5204/full/v16/i8/3481.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i8.3481

Full Article (PDF)	WJGO-16-3481-with-cover.pdf
Manuscript File	92699_Auto_Edited-YJP.docx
Answering Reviewers	92699-answering-reviewers.pdf
Audio Core Tip	92699-audio.m4a
Biostatistics Review Certificate	92699-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	92699-conflict-of-interest-statement.pdf
Copyright License Agreement	92699-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s)	92699-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document	92699-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate	92699-non-native-speakers.pdf
Supplementary Material	92699-supplementary-material.pdf
Peer-review Report	92699-peer-reviews.pdf
Scientific Misconduct Check	92699-scientific-misconduct-check.png
Scientific Editor Work List	92699-scientific-editor-work-list.pdf
CrossCheck Report	92699-crosscheck-report.pdf